Physician profile
Aditya Juloori
NPI 1952714636
$73,096.97
in general payments reported to CMS, 2019-2025
16 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,224 · 2022: $5,135 · 2023: $12K · 2024: $16K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $52K · Travel and Lodging: $7,814 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,770 · Food and Beverage: $2,002 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $51,943.50 |
| Travel and Lodging | $7,814.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,770.00 |
| Food and Beverage | $2,001.78 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $208.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $31,981.79 | 2023-2025 | Imfinzi, Enhertu, Tagrisso |
| Merck Sharp & Dohme LLC | $13,743.89 | 2024-2025 | Keytruda |
| Daiichi Sankyo INC. | $10,698.31 | 2022-2025 | |
| Emd Serono, INC. | $7,986.85 | 2023-2024 | |
| Ge Healthcare | $3,924.00 | 2022 | |
| Siemens Medical Solutions USA, INC. | $1,848.48 | 2023 | |
| Isoray, INC | $1,071.99 | 2021 | |
| Regeneron Pharmaceuticals, INC. | $824.24 | 2024 | Libtayo |
| Lantheus Medical Imaging, INC. | $500.00 | 2025 | |
| Taiho Oncology, INC. | $191.91 | 2025 | |
| Iba Proton Therapy, INC. | $134.00 | 2021 | |
| Tactile Systems Technology INC | $71.58 | 2022 | |
| Novartis Pharmaceuticals Corporation | $63.06 | 2024-2025 | |
| Medtronic, INC. | $39.15 | 2024 | Signia |
| Novocure INC. | $17.72 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Juloori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.